资源 » 技术资源中心 » 蛋白资源中心 » Antibody Handbook

Antibody Handbook

Antibodies (Abs) are the fastest growing class of drugs and the reasons for this growth are obvious. Their long half-lives allow for infrequent dosing. They have high specificity for their targets and are well tolerated. Recombinant DNA technology can be utilized to engineer improved binding or effector functions. Given some of these factors, there is a robust increase in the development of human monoclonal Abs for therapeutic purposes. As a result there has been a major shift in the focus of many pharmaceutical companies as they started moving from exclusive small molecule drug discovery to a broader portfolio containing both, chemical entities [small molecules] as well as biotherapeutics [large molecules including antibodies].

This Ab handbook serves to provide a broad overview of the discovery process for generation of Ab-based therapeutics, while discussing basic concepts around Ab production. Discovery topics include target selection, target assessment & validation, screening, lead identification and optimization, leading up to candidate selection.

GenScript's service capabilities in recombinant antibody (rAb) production are provided where necessary. Glossary of important terms in alphabetical order, along with references and suggestions for further reading, are provided at the end. This concise and colorful resource is available as a free PDF download.

• Download the Ab handbook (36-page PDF)

Antibody Drug Discovery Resources and Services

• Antibody Discovery: GenScript’s Antibody Engineering group can build antibody library with up to 10¹⁰ individual clones, to speed up your antibody discovery efforts.
• Antibody Sequencing: GenScript’s advanced Antibody Sequencing technology offers fast and professional sequencing services for your monoclonal antibodies.
• Antibody Engineering: GenScript scientists’ extensive experience in antibody engineering can provide superior services such as antibody humanization, affinity maturation and more.
• Antibody Production: With solid expertise in recombinant antibody (rAb) production techniques, GenScript provides a comprehensive rAb service portfolio that deliver microgram to gram quantities of pure rAb for each stage of your Ab drug discovery program.
• PK/PD Study: GenScript offers over 120 tumor and inflammation models for evaluation of in vivo efficacy, PK/PD, biomarker and bioanalysis studies. GenScript Anti-idiotype Antibody services are also a powerful tool for antibody drug PK/PD and immunogenicity studies.

You can also view our Recombinant Antibody Service Selection Guide to identify services that are the best match for your application.